A recent review of surgical treatments for hyperparathyroidism confirms that surgery remains the only curative option for this condition. The review highlights a major shift in surgical strategy over the years: from traditional bilateral neck exploration to precision-focused, minimally invasive parathyroidectomy. This change has been driven by advances in preoperative localization, intraoperative PTH monitoring, and remote-access endoscopic approaches.
The review covers primary, secondary, and tertiary hyperparathyroidism, providing a framework for diagnosis and selection of surgical treatment strategies. However, it does not report specific data on the efficacy or safety of these emerging techniques, nor does it include details on sample size, follow-up, or adverse events.
While the review offers a useful overview for clinicians, readers should note that it is a narrative review without quantitative results or direct comparisons. The information is based on expert opinion and existing literature, not new clinical trial data. For patients, the key takeaway is that surgery is the only curative treatment, but individual risks and benefits should be discussed with a healthcare provider.
